Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        

Generate Chart For    
    (Chart displayed below)
Rat Strains
{{sample.term}}
Measurement Methods
{{method.term}}
Age
{{ageRange}}
Experimental Conditions
     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord IDCondition 1Condition 2aCondition 2bCondition 3Condition 4
10methylene blue metabolism-surface area product after auto-oxidationFHH-Chr 8BN/Mcwifemale19.3371ml/min/kgair oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours)57599air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)sample resting period (for 0.1 hours)
10methylene blue metabolism-surface area product after auto-oxidationFHH-Chr 8BN/Mcwimale16.452ml/min/kgair oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours)57603air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)sample resting period (for 0.1 hours)
10methylene blue metabolism-surface area product without auto-oxidationFHH-Chr 8BN/Mcwifemale28.922ml/min/kgair oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours)57801air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)
10methylene blue metabolism-surface area product without auto-oxidationFHH-Chr 8BN/Mcwimale24.5022ml/min/kgair oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours)57805air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)
10heart wet weightFHH-Chr 8BN/Mcwifemale0.927gair oxygen content (12 %) (for 14 days)45406air oxygen content (12 %) (for 14 days)
10heart wet weightFHH-Chr 8BN/Mcwimale1.014gair oxygen content (12 %) (for 14 days)45410air oxygen content (12 %) (for 14 days)
11percent change in respiration rateFHH-Chr 8BN/Mcwifemale139.2725%air oxygen content (12 %) (between 0 and 0.1 hours)54328air oxygen content (12 %) (between 0 and 0.1 hours)
9percent change in respiration rateFHH-Chr 8BN/Mcwimale128.5562%air oxygen content (12 %) (between 0 and 0.1 hours)54332air oxygen content (12 %) (between 0 and 0.1 hours)
10arterial blood flow rateFHH-Chr 8BN/Mcwifemale6.699ml/min/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)44719air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
10arterial blood flow rateFHH-Chr 8BN/Mcwimale4.773ml/min/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)44723air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
7heart rateFHH-Chr 8BN/Mcwifemale182.8357beats/minair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)45149air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9heart rateFHH-Chr 8BN/Mcwimale196.96beats/minair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)45153air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
8left ventricular developed pressureFHH-Chr 8BN/Mcwifemale45.5238mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)45271air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9left ventricular developed pressureFHH-Chr 8BN/Mcwimale43.7811mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)45275air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
8left ventricular systolic blood pressureFHH-Chr 8BN/Mcwifemale90.6938mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)49889air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9left ventricular systolic blood pressureFHH-Chr 8BN/Mcwimale77.9111mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)49893air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
8heart contraction pressureFHH-Chr 8BN/Mcwifemale34mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)49998air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
9heart contraction pressureFHH-Chr 8BN/Mcwimale29.6667mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)50002air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
8time to peak heart contractionFHH-Chr 8BN/Mcwifemale1172.5sair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)50228air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
9time to peak heart contractionFHH-Chr 8BN/Mcwimale1155.2222sair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)50232air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
10body weightFHH-Chr 8BN/Mcwifemale136.1gair oxygen content (12 %) (for 14 days)49529air oxygen content (12 %) (for 14 days)
10body weightFHH-Chr 8BN/Mcwimale140gair oxygen content (12 %) (for 14 days)49541air oxygen content (12 %) (for 14 days)
10heart left ventricle infarction weight to total heart left ventricle weight ratioFHH-Chr 8BN/Mcwifemale1.828%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours)49699air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 3 hours)
10heart left ventricle infarction weight to total heart left ventricle weight ratioFHH-Chr 8BN/Mcwimale7.381%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours)49703air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 3 hours)
8time to onset of heart contractionFHH-Chr 8BN/Mcwifemale902.75sair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)49300air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
9time to onset of heart contractionFHH-Chr 8BN/Mcwimale971.4444sair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)49304air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
11tidal volumeFHH-Chr 8BN/Mcwifemale0.2833mlair oxygen content (12 %) (between 0 and 0.1 hours)13924air oxygen content (12 %) (between 0 and 0.1 hours)
9tidal volumeFHH-Chr 8BN/Mcwimale0.3328mlair oxygen content (12 %) (between 0 and 0.1 hours)13928air oxygen content (12 %) (between 0 and 0.1 hours)
6dose of methacholine at which pulmonary conductance is half its pretreatment valueFHH-Chr 8BN/Mcwimale2.9423mg/kgair oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours)58911air oxygen content (12 %) (for 14 days)methacholine (0-11.06 mg/kg) drug dose time series (for 0.2 hours)
9percent change in ventilationFHH-Chr 8BN/Mcwimale141.3502%air oxygen content (12 %) (between 0 and 0.1 hours)13685air oxygen content (12 %) (between 0 and 0.1 hours)
11percent change in tidal volumeFHH-Chr 8BN/Mcwifemale96.7738%air oxygen content (12 %) (between 0.1 and 0.1 hours)53988air oxygen content (12 %) (between 0.1 and 0.1 hours)
9percent change in tidal volumeFHH-Chr 8BN/Mcwimale106.8449%air oxygen content (12 %) (between 0.1 and 0.1 hours)53992air oxygen content (12 %) (between 0.1 and 0.1 hours)
10serum alkaline phosphatase activity levelFHH-Chr 8BN/Mcwifemale299.5U/lair oxygen content (12 %) (for 14 days)36380air oxygen content (12 %) (for 14 days)
10serum alkaline phosphatase activity levelFHH-Chr 8BN/Mcwimale384.2U/lair oxygen content (12 %) (for 14 days)36384air oxygen content (12 %) (for 14 days)
9heart right ventricle weight to left ventricle weight ratioFHH-Chr 8BN/Mcwifemale0.4118air oxygen content (12 %) (for 14 days)58734air oxygen content (12 %) (for 14 days)
10heart right ventricle weight to left ventricle weight ratioFHH-Chr 8BN/Mcwimale0.3792air oxygen content (12 %) (for 14 days)58738air oxygen content (12 %) (for 14 days)
10body weightFHH-Chr 8BN/Mcwifemale144.3gair oxygen content (12 %) (for 14 days)59063air oxygen content (12 %) (for 14 days)
10body weightFHH-Chr 8BN/Mcwimale168.4gair oxygen content (12 %) (for 14 days)59067air oxygen content (12 %) (for 14 days)
6absolute change in blood pHFHH-Chr 8BN/Mcwifemale0.0467air oxygen content (12 %) (for 0.1 hours)19784air oxygen content (12 %) (for 0.1 hours)
6absolute change in blood pHFHH-Chr 8BN/Mcwimale0.0498air oxygen content (12 %) (for 0.1 hours)19794air oxygen content (12 %) (for 0.1 hours)
10hematocritFHH-Chr 8BN/Mcwifemale52.84%air oxygen content (12 %) (for 14 days)59258air oxygen content (12 %) (for 14 days)
10hematocritFHH-Chr 8BN/Mcwimale53.77%air oxygen content (12 %) (for 14 days)59262air oxygen content (12 %) (for 14 days)
10calculated pulmonary vascular resistance normalized to body weightFHH-Chr 8BN/Mcwifemale0.1624mmHg x min x kg x ml-1air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours)59548air oxygen content (12 %) (for 14 days)Kreb's solution perfusate (between 0.2 and 0.2 hours)
10calculated pulmonary vascular resistance normalized to body weightFHH-Chr 8BN/Mcwimale0.1606mmHg x min x kg x ml-1air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours)59552air oxygen content (12 %) (for 14 days)Kreb's solution perfusate (between 0.2 and 0.2 hours)
10lung dry weight to body weight ratioFHH-Chr 8BN/Mcwifemale1.7612g/kgair oxygen content (12 %) (for 14 days)59658air oxygen content (12 %) (for 14 days)
10lung dry weight to body weight ratioFHH-Chr 8BN/Mcwimale1.544g/kgair oxygen content (12 %) (for 14 days)59662air oxygen content (12 %) (for 14 days)
10fractional change in blood vessel diameter per unit change in intravascular pressureFHH-Chr 8BN/Mcwifemale0.0292mmHg-1air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours)58490air oxygen content (12 %) (for 14 days)Kreb's solution perfusate (between 0.2 and 0.2 hours)
10fractional change in blood vessel diameter per unit change in intravascular pressureFHH-Chr 8BN/Mcwimale0.0288mmHg-1air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours)58494air oxygen content (12 %) (for 14 days)Kreb's solution perfusate (between 0.2 and 0.2 hours)
9dose of methacholine at which pulmonary conductance is half its pretreatment valueFHH-Chr 8BN/Mcwifemale2.275mg/kgair oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours)58907air oxygen content (12 %) (for 14 days)methacholine (0-11.06 mg/kg) drug dose time series (for 0.2 hours)
10serum chloride levelFHH-Chr 8BN/Mcwimale105.2mmol/lair oxygen content (12 %) (for 14 days)39122air oxygen content (12 %) (for 14 days)
10total white blood cell countFHH-Chr 8BN/Mcwifemale5.29x 1000 cells/ulair oxygen content (12 %) (for 14 days)40927air oxygen content (12 %) (for 14 days)
10total white blood cell countFHH-Chr 8BN/Mcwimale6.05x 1000 cells/ulair oxygen content (12 %) (for 14 days)40931air oxygen content (12 %) (for 14 days)
9serum aspartate aminotransferase activity levelFHH-Chr 8BN/Mcwifemale99.5556U/lair oxygen content (12 %) (for 14 days)42771air oxygen content (12 %) (for 14 days)
10serum aspartate aminotransferase activity levelFHH-Chr 8BN/Mcwimale93.1U/lair oxygen content (12 %) (for 14 days)42775air oxygen content (12 %) (for 14 days)
10red blood cell countFHH-Chr 8BN/Mcwifemale9.06x 10E6 cells/ulair oxygen content (12 %) (for 14 days)39238air oxygen content (12 %) (for 14 days)
10red blood cell countFHH-Chr 8BN/Mcwimale9.546x 10E6 cells/ulair oxygen content (12 %) (for 14 days)39242air oxygen content (12 %) (for 14 days)
10serum phosphate levelFHH-Chr 8BN/Mcwifemale7.9mg/dlair oxygen content (12 %) (for 14 days)37595air oxygen content (12 %) (for 14 days)
10serum phosphate levelFHH-Chr 8BN/Mcwimale8.19mg/dlair oxygen content (12 %) (for 14 days)37599air oxygen content (12 %) (for 14 days)
10serum sodium levelFHH-Chr 8BN/Mcwifemale140.5mmol/lair oxygen content (12 %) (for 14 days)39389air oxygen content (12 %) (for 14 days)
10serum sodium levelFHH-Chr 8BN/Mcwimale140.5mmol/lair oxygen content (12 %) (for 14 days)39393air oxygen content (12 %) (for 14 days)
10plasma creatinine levelFHH-Chr 8BN/Mcwifemale0.27mg/dlair oxygen content (12 %) (for 14 days)39577air oxygen content (12 %) (for 14 days)
10plasma creatinine levelFHH-Chr 8BN/Mcwimale0.3mg/dlair oxygen content (12 %) (for 14 days)39581air oxygen content (12 %) (for 14 days)
10blood monocyte countFHH-Chr 8BN/Mcwifemale0.164x 1000 cells/ulair oxygen content (12 %) (for 14 days)39675air oxygen content (12 %) (for 14 days)
10blood monocyte countFHH-Chr 8BN/Mcwimale0.255x 1000 cells/ulair oxygen content (12 %) (for 14 days)39679air oxygen content (12 %) (for 14 days)
10FAPGG metabolism-surface area productFHH-Chr 8BN/Mcwifemale54.6284ml/min/kgair oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours)58000air oxygen content (12 %) (for 14 days)FAPGG (0.6 mmol/l) (between 0 and 0 hours)
10FAPGG metabolism-surface area productFHH-Chr 8BN/Mcwimale58.5749ml/min/kgair oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours)58004air oxygen content (12 %) (for 14 days)FAPGG (0.6 mmol/l) (between 0 and 0 hours)
10mean corpuscular hemoglobin concentrationFHH-Chr 8BN/Mcwifemale31.79g/dlair oxygen content (12 %) (for 14 days)39778air oxygen content (12 %) (for 14 days)
10mean corpuscular hemoglobin concentrationFHH-Chr 8BN/Mcwimale32.34g/dlair oxygen content (12 %) (for 14 days)39782air oxygen content (12 %) (for 14 days)
10blood lymphocyte countFHH-Chr 8BN/Mcwifemale4.477x 1000 cells/ulair oxygen content (12 %) (for 14 days)41504air oxygen content (12 %) (for 14 days)
10blood lymphocyte countFHH-Chr 8BN/Mcwimale4.911x 1000 cells/ulair oxygen content (12 %) (for 14 days)41508air oxygen content (12 %) (for 14 days)
10blood hemoglobin levelFHH-Chr 8BN/Mcwifemale16.81g/dlair oxygen content (12 %) (for 14 days)37969air oxygen content (12 %) (for 14 days)
10blood hemoglobin levelFHH-Chr 8BN/Mcwimale17.39g/dlair oxygen content (12 %) (for 14 days)37973air oxygen content (12 %) (for 14 days)
10serum potassium levelFHH-Chr 8BN/Mcwifemale4.45mmol/lair oxygen content (12 %) (for 14 days)38067air oxygen content (12 %) (for 14 days)
10serum potassium levelFHH-Chr 8BN/Mcwimale4.44mmol/lair oxygen content (12 %) (for 14 days)38071air oxygen content (12 %) (for 14 days)
10blood eosinophil countFHH-Chr 8BN/Mcwifemale0.041x 1000 cells/ulair oxygen content (12 %) (for 14 days)41648air oxygen content (12 %) (for 14 days)
10blood eosinophil countFHH-Chr 8BN/Mcwimale0.031x 1000 cells/ulair oxygen content (12 %) (for 14 days)41652air oxygen content (12 %) (for 14 days)
10methylene blue to FAPGG metabolism-surface area product ratioFHH-Chr 8BN/Mcwifemale0.552air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours)58114air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)
10methylene blue to FAPGG metabolism-surface area product ratioFHH-Chr 8BN/Mcwimale0.431air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours)58118air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)
10plasma anion gapFHH-Chr 8BN/Mcwifemale17.9mmol/lair oxygen content (12 %) (for 14 days)38262air oxygen content (12 %) (for 14 days)
10plasma anion gapFHH-Chr 8BN/Mcwimale19.4mmol/lair oxygen content (12 %) (for 14 days)38266air oxygen content (12 %) (for 14 days)
10serum total bilirubin levelFHH-Chr 8BN/Mcwifemale0.115mg/dlair oxygen content (12 %) (for 14 days)41869air oxygen content (12 %) (for 14 days)
10serum total bilirubin levelFHH-Chr 8BN/Mcwimale0.11mg/dlair oxygen content (12 %) (for 14 days)41873air oxygen content (12 %) (for 14 days)
10blood neutrophil countFHH-Chr 8BN/Mcwifemale0.592x 1000 cells/ulair oxygen content (12 %) (for 14 days)43225air oxygen content (12 %) (for 14 days)
10blood neutrophil countFHH-Chr 8BN/Mcwimale0.851x 1000 cells/ulair oxygen content (12 %) (for 14 days)43229air oxygen content (12 %) (for 14 days)
10serum calcium levelFHH-Chr 8BN/Mcwifemale9.36mg/dlair oxygen content (12 %) (for 14 days)36625air oxygen content (12 %) (for 14 days)
10serum calcium levelFHH-Chr 8BN/Mcwimale9.64mg/dlair oxygen content (12 %) (for 14 days)36629air oxygen content (12 %) (for 14 days)
10serum glucose levelFHH-Chr 8BN/Mcwifemale138.5mg/dlair oxygen content (12 %) (for 14 days)38531air oxygen content (12 %) (for 14 days)
9serum glucose levelFHH-Chr 8BN/Mcwimale147.8889mg/dlair oxygen content (12 %) (for 14 days)38535air oxygen content (12 %) (for 14 days)
10serum bicarbonate levelFHH-Chr 8BN/Mcwifemale20.5mmol/lair oxygen content (12 %) (for 14 days)42063air oxygen content (12 %) (for 14 days)
10serum bicarbonate levelFHH-Chr 8BN/Mcwimale20.4mmol/lair oxygen content (12 %) (for 14 days)42067air oxygen content (12 %) (for 14 days)
10mean corpuscular volumeFHH-Chr 8BN/Mcwifemale58.33flair oxygen content (12 %) (for 14 days)38746air oxygen content (12 %) (for 14 days)
10mean corpuscular volumeFHH-Chr 8BN/Mcwimale56.36flair oxygen content (12 %) (for 14 days)38750air oxygen content (12 %) (for 14 days)
10serum globulin levelFHH-Chr 8BN/Mcwifemale1.34g/dlair oxygen content (12 %) (for 14 days)40551air oxygen content (12 %) (for 14 days)
10serum globulin levelFHH-Chr 8BN/Mcwimale1.5g/dlair oxygen content (12 %) (for 14 days)40555air oxygen content (12 %) (for 14 days)
10serum albumin levelFHH-Chr 8BN/Mcwifemale3.88g/dlair oxygen content (12 %) (for 14 days)42234air oxygen content (12 %) (for 14 days)
10serum albumin levelFHH-Chr 8BN/Mcwimale3.89g/dlair oxygen content (12 %) (for 14 days)42238air oxygen content (12 %) (for 14 days)
10serum total protein levelFHH-Chr 8BN/Mcwifemale5.22g/dlair oxygen content (12 %) (for 14 days)36963air oxygen content (12 %) (for 14 days)
10serum total protein levelFHH-Chr 8BN/Mcwimale5.39g/dlair oxygen content (12 %) (for 14 days)36967air oxygen content (12 %) (for 14 days)
10serum alanine aminotransferase activity levelFHH-Chr 8BN/Mcwifemale46.6U/lair oxygen content (12 %) (for 14 days)40715air oxygen content (12 %) (for 14 days)
10serum alanine aminotransferase activity levelFHH-Chr 8BN/Mcwimale53.7U/lair oxygen content (12 %) (for 14 days)40719air oxygen content (12 %) (for 14 days)
10serum total cholesterol levelFHH-Chr 8BN/Mcwifemale59.4mg/dlair oxygen content (12 %) (for 14 days)37098air oxygen content (12 %) (for 14 days)
10serum total cholesterol levelFHH-Chr 8BN/Mcwimale75mg/dlair oxygen content (12 %) (for 14 days)37102air oxygen content (12 %) (for 14 days)
10hematocritFHH-Chr 8BN/Mcwifemale52.84%air oxygen content (12 %) (for 14 days)38992air oxygen content (12 %) (for 14 days)
10hematocritFHH-Chr 8BN/Mcwimale53.77%air oxygen content (12 %) (for 14 days)38996air oxygen content (12 %) (for 14 days)
10serum urea nitrogen levelFHH-Chr 8BN/Mcwifemale19.8mg/dlair oxygen content (12 %) (for 14 days)40829air oxygen content (12 %) (for 14 days)
10serum urea nitrogen levelFHH-Chr 8BN/Mcwimale21mg/dlair oxygen content (12 %) (for 14 days)40833air oxygen content (12 %) (for 14 days)
10mean corpuscular hemoglobinFHH-Chr 8BN/Mcwifemale18.56pgair oxygen content (12 %) (for 14 days)42546air oxygen content (12 %) (for 14 days)
10mean corpuscular hemoglobinFHH-Chr 8BN/Mcwimale18.22pgair oxygen content (12 %) (for 14 days)42550air oxygen content (12 %) (for 14 days)
10serum chloride levelFHH-Chr 8BN/Mcwifemale106.6mmol/lair oxygen content (12 %) (for 14 days)39118air oxygen content (12 %) (for 14 days)
9arterial blood flow rateFHH-Chr 8BN/Mcwifemale13.0467ml/min/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)46654air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
10arterial blood flow rateFHH-Chr 8BN/Mcwimale12.968ml/min/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)46658air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
7percent change in heart rateFHH-Chr 8BN/Mcwifemale73.3433%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48296air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9percent change in heart rateFHH-Chr 8BN/Mcwimale84.035%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48300air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
5percent change in left ventricular developed pressureFHH-Chr 8BN/Mcwifemale35.7058%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48528air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
5percent change in left ventricular developed pressureFHH-Chr 8BN/Mcwimale44.3938%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48532air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
5left ventricular developed pressureFHH-Chr 8BN/Mcwifemale155.52mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)48625air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
5left ventricular developed pressureFHH-Chr 8BN/Mcwimale117.22mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)48629air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
5percent change in left ventricular systolic blood pressureFHH-Chr 8BN/Mcwifemale72.9376%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48757air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
5percent change in left ventricular systolic blood pressureFHH-Chr 8BN/Mcwimale76.332%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48761air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
11respiration rateFHH-Chr 8BN/Mcwifemale140.1305breaths/minair oxygen content (12 %) (between 0 and 0.1 hours)18266air oxygen content (12 %) (between 0 and 0.1 hours)
9respiration rateFHH-Chr 8BN/Mcwimale135.4833breaths/minair oxygen content (12 %) (between 0 and 0.1 hours)18270air oxygen content (12 %) (between 0 and 0.1 hours)
11percent change in respiration rateFHH-Chr 8BN/Mcwifemale122.51%air oxygen content (12 %) (between 0.1 and 0.1 hours)53755air oxygen content (12 %) (between 0.1 and 0.1 hours)
9percent change in respiration rateFHH-Chr 8BN/Mcwimale126.9383%air oxygen content (12 %) (between 0.1 and 0.1 hours)53759air oxygen content (12 %) (between 0.1 and 0.1 hours)
11percent change in tidal volumeFHH-Chr 8BN/Mcwifemale103.8797%air oxygen content (12 %) (between 0 and 0.1 hours)53887air oxygen content (12 %) (between 0 and 0.1 hours)
9percent change in tidal volumeFHH-Chr 8BN/Mcwimale108.5606%air oxygen content (12 %) (between 0 and 0.1 hours)53891air oxygen content (12 %) (between 0 and 0.1 hours)
11body temperatureFHH-Chr 8BN/Mcwifemale36.9degrees Cair oxygen content (12 %) (for 0.1 hours)16573air oxygen content (12 %) (for 0.1 hours)
9body temperatureFHH-Chr 8BN/Mcwimale36.8444degrees Cair oxygen content (12 %) (for 0.1 hours)16577air oxygen content (12 %) (for 0.1 hours)
11respiration rateFHH-Chr 8BN/Mcwifemale122.3345breaths/minair oxygen content (12 %) (between 0.1 and 0.1 hours)14795air oxygen content (12 %) (between 0.1 and 0.1 hours)
9respiration rateFHH-Chr 8BN/Mcwimale133.4993breaths/minair oxygen content (12 %) (between 0.1 and 0.1 hours)14799air oxygen content (12 %) (between 0.1 and 0.1 hours)
10heart weight to body weight ratioFHH-Chr 8BN/Mcwifemale6.823g/kgair oxygen content (12 %) (for 14 days)45627air oxygen content (12 %) (for 14 days)
10heart weight to body weight ratioFHH-Chr 8BN/Mcwimale7.418g/kgair oxygen content (12 %) (for 14 days)45639air oxygen content (12 %) (for 14 days)
9heart effluent lactate dehydrogenase activity level normalized to heart weightFHH-Chr 8BN/Mcwifemale0.5125IU/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47456air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
10heart effluent lactate dehydrogenase activity level normalized to heart weightFHH-Chr 8BN/Mcwimale0.5219IU/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47466air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
5left ventricular systolic blood pressureFHH-Chr 8BN/Mcwifemale161.54mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)45730air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
5left ventricular systolic blood pressureFHH-Chr 8BN/Mcwimale123.32mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)45734air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
8left ventricular diastolic blood pressureFHH-Chr 8BN/Mcwifemale45.17mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)46418air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9left ventricular diastolic blood pressureFHH-Chr 8BN/Mcwimale34.13mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)46422air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
10percent change in arterial blood flow rateFHH-Chr 8BN/Mcwifemale44.0071%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)47078air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
10percent change in arterial blood flow rateFHH-Chr 8BN/Mcwimale37.145%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)47082air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
7heart rateFHH-Chr 8BN/Mcwifemale251.7943beats/minair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47583air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
9heart rateFHH-Chr 8BN/Mcwimale235.5222beats/minair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47587air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
6left ventricular diastolic blood pressureFHH-Chr 8BN/Mcwifemale5.95mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47198air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
8left ventricular diastolic blood pressureFHH-Chr 8BN/Mcwimale5.53mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47202air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
10heart effluent lactate dehydrogenase activity level normalized to heart weightFHH-Chr 8BN/Mcwifemale22.8159IU/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours)45974air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 1.5 hours)
10heart effluent lactate dehydrogenase activity level normalized to heart weightFHH-Chr 8BN/Mcwimale22.8014IU/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours)45982air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 1.5 hours)
6absolute change in partial pressure of blood oxygenFHH-Chr 8BN/Mcwifemale-43.7083mmHgair oxygen content (12 %) (for 0.1 hours)19463air oxygen content (12 %) (for 0.1 hours)
6absolute change in partial pressure of blood oxygenFHH-Chr 8BN/Mcwimale-44.8mmHgair oxygen content (12 %) (for 0.1 hours)19474air oxygen content (12 %) (for 0.1 hours)
11tidal volumeFHH-Chr 8BN/Mcwifemale0.2626mlair oxygen content (12 %) (between 0.1 and 0.1 hours)15234air oxygen content (12 %) (between 0.1 and 0.1 hours)
9tidal volumeFHH-Chr 8BN/Mcwimale0.3291mlair oxygen content (12 %) (between 0.1 and 0.1 hours)15238air oxygen content (12 %) (between 0.1 and 0.1 hours)
6blood pHFHH-Chr 8BN/Mcwifemale7.4884air oxygen content (12 %) (for 0.1 hours)17048air oxygen content (12 %) (for 0.1 hours)
6blood pHFHH-Chr 8BN/Mcwimale7.5006air oxygen content (12 %) (for 0.1 hours)17059air oxygen content (12 %) (for 0.1 hours)
8mean arterial blood pressureFHH-Chr 8BN/Mcwifemale116.7362mmHgair oxygen content (12 %) (for 0.1 hours)14330air oxygen content (12 %) (for 0.1 hours)
6mean arterial blood pressureFHH-Chr 8BN/Mcwimale115.4283mmHgair oxygen content (12 %) (for 0.1 hours)14341air oxygen content (12 %) (for 0.1 hours)
11minute ventilationFHH-Chr 8BN/Mcwifemale32.0066ml/minair oxygen content (12 %) (between 0.1 and 0.1 hours)20209air oxygen content (12 %) (between 0.1 and 0.1 hours)
9minute ventilationFHH-Chr 8BN/Mcwimale43.8687ml/minair oxygen content (12 %) (between 0.1 and 0.1 hours)20213air oxygen content (12 %) (between 0.1 and 0.1 hours)
11percent change in ventilationFHH-Chr 8BN/Mcwifemale148.0066%air oxygen content (12 %) (between 0 and 0.1 hours)13681air oxygen content (12 %) (between 0 and 0.1 hours)
6absolute change in partial pressure of blood carbon dioxideFHH-Chr 8BN/Mcwifemale-8.05mmHgair oxygen content (12 %) (for 0.1 hours)19632air oxygen content (12 %) (for 0.1 hours)
6absolute change in partial pressure of blood carbon dioxideFHH-Chr 8BN/Mcwimale-6.4333mmHgair oxygen content (12 %) (for 0.1 hours)19643air oxygen content (12 %) (for 0.1 hours)
11absolute change in body temperatureFHH-Chr 8BN/Mcwifemale0.0636degrees Cair oxygen content (12 %) (for 0.1 hours)20310air oxygen content (12 %) (for 0.1 hours)
9absolute change in body temperatureFHH-Chr 8BN/Mcwimale0.0667degrees Cair oxygen content (12 %) (for 0.1 hours)20314air oxygen content (12 %) (for 0.1 hours)
6partial pressure of blood carbon dioxide (Pco2)FHH-Chr 8BN/Mcwifemale28.9583mmHgair oxygen content (12 %) (for 0.1 hours)17240air oxygen content (12 %) (for 0.1 hours)
6partial pressure of blood carbon dioxide (Pco2)FHH-Chr 8BN/Mcwimale29.8667mmHgair oxygen content (12 %) (for 0.1 hours)17251air oxygen content (12 %) (for 0.1 hours)
8heart rateFHH-Chr 8BN/Mcwifemale394.4538beats/minair oxygen content (12 %) (for 0.1 hours)17503air oxygen content (12 %) (for 0.1 hours)
6heart rateFHH-Chr 8BN/Mcwimale395.9167beats/minair oxygen content (12 %) (for 0.1 hours)17514air oxygen content (12 %) (for 0.1 hours)
11minute ventilationFHH-Chr 8BN/Mcwifemale39.5638ml/minair oxygen content (12 %) (between 0 and 0.1 hours)18663air oxygen content (12 %) (between 0 and 0.1 hours)
9minute ventilationFHH-Chr 8BN/Mcwimale45.2492ml/minair oxygen content (12 %) (between 0 and 0.1 hours)18667air oxygen content (12 %) (between 0 and 0.1 hours)
6partial pressure of blood oxygenFHH-Chr 8BN/Mcwifemale54.3083mmHgair oxygen content (12 %) (for 0.1 hours)20475air oxygen content (12 %) (for 0.1 hours)
6partial pressure of blood oxygenFHH-Chr 8BN/Mcwimale51.0417mmHgair oxygen content (12 %) (for 0.1 hours)20486air oxygen content (12 %) (for 0.1 hours)

Contact Us |  About Us |  Jobs at RGD